Inventor · disambiguated record
Wubin Pan
Also filed as: PAN WUBIN
5 granted patents·4 pending applications·34 citations·filing 2014–2024
76Inventor score
Top patents by PatentIndex Score
9 records- 0196US10774141B2Antibody for binding to interleukin 4 receptorSUZHOU CONNECT BIOPHARMACEUTICALS LTD·Filed 2020·Granted Sep 15, 2020·29 cites·25 claims
- 0284US11866491B2Antibody for binding to interleukin 4 receptorSUZHOU CONNECT BIOPHARMACEUTICALS LTD·Filed 2020·Granted Jan 9, 2024·1 cites·32 claims
- 0382US11512078B2Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical compositionSUZHOU CONNECT BIOPHARMACEUTICALS LTD·Filed 2018·Granted Nov 29, 2022·2 cites·14 claims
- 0474US12202822B2Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical compositionSUZHOU CONNECT BIOPHARMACEUTICALS LTD·Filed 2022·Granted Jan 21, 2025·0 cites·17 claims
- 0573US10280158B2Immune adjustment compound, use thereof and pharmaceutical composition comprising sameSUZHOU CONNECT BIOPHARMACEUTICALS LTD·Filed 2014·Granted May 7, 2019·2 cites·25 claims
- 0673US2025320200A1Addition salt of s1p1 receptor agonist and crystal form thereof, and pharmaceutical compositionSUZHOU CONNECT BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0758US2019177408A1Antibody for binding to interleukin 4 receptorSUZHOU CONNECT BIOPHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 0853US2023167180A1Antibody binding with specific epitope in human il-4r alpha and applications of antibodySUZHOU CONNECT BIOPHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 0950US2022348666A1Liquid composition comprising antibody of human interleukin-4 receptor alphaSUZHOU CONNECT BIOPHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →